CKD affects 10% of the world’s population1 and ranks in the top ten noncommunicable diseases contributing to disease and disability.2 Its incidence is increasing worldwide,1 and mortality owing to CKD rose between 2005 and 2017 from 0.9 million to 1.2 million deaths annually.2 CKD imposes a significant economic burden on patients and society; many developed countries spend between 2% and 3% of their annual health care expenditure on RRTs (that is, chronic dialysis or kidney transplantation) for 0.2% of the total population.3
Because prevention is more effective than cure, avoiding exposures to hazards that may cause CKD in the community is a key priority. This is particularly important because the management of patients with established CKD may require dietary adaptations that diametrically differ from those that are needed for primary prevention.4 However, no evidence-based lifestyle recommendations for the primary prevention of CKD are apparent. Instead, current advice extrapolates from recommendations and inferences drawn from literature concerning cardiovascular disease, hypertension, and diabetes.5–7 Furthermore, the World Health Organization discusses CKD as a complication of cardiovascular disease and diabetes, which further complicates effective public health messages.8 To address this critical knowledge gap, we hereby evaluated the consistency of evidence associating modifiable lifestyle factors (specifically diet, physical activity, alcohol consumption, and tobacco smoking) and the incidence of CKD.
Methods
This systematic review and meta-analysis was conducted according to the Meta-analysis of Observational Studies in Epidemiology checklist for observational studies,9 and it was prospectively registered in PROSPERO (CRD42019137328).
Data Sources and Searches
We searched MEDLINE, Embase, and CINAHL (database inception through June 2019) without date or language restriction (Supplemental Table 1). We used EndNote to deduplicate and manage citations. For publications in languages other than English, we used translations by native speakers and where not possible, Google Translate. Author pairs completed the title and abstract screening and full-text screening, and they manually searched the reference lists of eligible studies and reviews to identify other potentially relevant studies by snowballing. We included a third investigator (J.T.K. or J.-J.C.) and used consensus to resolve disagreements.
Study Selection
Inclusion criteria were adult participants without established CKD (i.e., GFR>60 ml/min2) at baseline,10 including those that reported people without CKD as a subgroup of a larger study; cohort studies, prospective or retrospective; and outcome data (primary or secondary) reported on the basis of levels of exposure to a lifestyle factor, including diet (foods or nutrients), physical activity, alcohol consumption, and tobacco smoking. We excluded studies of participants with albuminuria at baseline, whenever this information was available. We did not consider diet pattern exposures in our review, as these have recently been systematically evaluated.11,12
The primary outcome was incident CKD, defined as the development of GFR<60 ml/min per 1.73 m2 during follow-up.10 Secondary outcomes were other surrogate measures of CKD: RRT, GFR decline, or albuminuria.
Data Extraction and Quality Assessment
One author from each team extracted the data from the included studies using standardized data extraction forms created in Microsoft Excel, which were checked by a second author before analysis. Supplemental Table 2 shows the data extracted for analysis. Where we identified more than one publication for a single cohort study reporting on the same lifestyle factor, we used the dataset from the published study contributing the highest number of participants. Within each meta-analysis, we conducted a sensitivity analysis examining the effects of substituting these alternative sources of data on the same cohort. Where questions arose concerning a study’s eligibility, missing data, or further information on results, we contacted corresponding authors to request this information. We used author responses to make decisions on a study’s eligibility and analysis approach.
We assessed risk of bias for each included study using the Newcastle–Ottawa Quality Assessment Scale,13 which assesses the methodological quality of the studies across three domains: selection (or representativeness) of cohorts, comparability (of cohorts due to design or analysis), and outcomes (assessment and follow-up) (Supplemental Table 2). We applied the Grading of Recommendations Assessment, Development and Evaluation methodology (GRADE) criteria to rate the quality of evidence (low, moderate, or high) for each outcome. In analyses that included five or more studies, when the primary outcome showed low or moderate heterogeneity, we constructed funnel plots to examine for effects that may represent publication, selection, or reporting bias.
Data Synthesis and Analyses
We used RevMan 5.3 and Stata version 16.0 (StataCorp, College Station, TX) to meta-analyze data when a particular lifestyle factor was reported for the same outcome from three separate cohorts; otherwise, associations were tabulated and reported using frequencies. Given the observational design and highly varied sample sizes of the primary studies, we used the random effects model (DerSimonian and Laird) for all meta-analyses. Robustness of the association estimate was evaluated by comparing if any statistically significant association identified through random effect models became nonsignificant under a fixed effects model. The overall association estimates for all binary outcomes are expressed as odds ratios (ORs) or relative risks (RRs), depending on which ratio was predominantly used in the original data, together with 95% confidence intervals (95% CIs). For studies reporting changes in mean values at the end of their observation follow-up periods, we extracted and tabulated the end of the study values with their associated variance. If the association compared a lifestyle factor with a reference exposure that was not homogenous with the other included lifestyle exposures (e.g., high adherence versus low adherence), then the ratio methods were inverted and combined into the meta-analysis. We used chi-squared testing at an α of 0.05 and with the I2 statistic, rated low (<25%), moderate (25%–75%), or high (>75%) to assess for heterogeneity. Supplemental Table 2 gives details of planned subgroup and sensitivity analyses to explore reasons for heterogeneity. In addition to these linear analyses for alcohol consumption, we also conducted a dose-response random effects metaregression analysis to account for potential changes in the risk estimate at different dosages of alcohol consumption (methods are reported in Supplemental Table 2).
Results
The electronic search retrieved 45,111 citations, of which a total of 104 studies encompassing 2,755,719 participants met the inclusion criteria (Supplemental Figure 1). The characteristics of included studies are reported in Supplemental Table 3. Lifestyle exposures and associations to kidney outcomes varied across the studies, with n=56 reporting diet exposures, n=18 reporting physical activity, n=27 reporting alcohol consumption, and n=30 reporting tobacco smoking. The outcomes evaluated included incident CKD in n=51 studies, RRT in n=17 studies, GFR decline in n=32 studies, and albuminuria in n=20 studies.
Lifestyle Hazards and Incident CKD
The association between lifestyle factors and incident CKD was reported in 51 studies of 1,221,018.14–72 The main results of the meta-analysis are summarized in Supplemental Figure 2.
Diet
The association between 57 different dietary factors with incident CKD was described in 31 studies of 176,625 participants.14,20,24,26,27,30,38,39,41,46,47,49,51,57,60,61,66,69,70 Meta-analysis was possible for nine dietary factors (Table 1), of which higher vegetable intake (OR, 0.79; 95% CI, 0.70 to 0.90; I2=57%; evidence quality: low) and higher potassium intake (OR, 0.78; 95% CI, 0.65 to 0.94; I2=48%; evidence quality: low) were consistently associated with lower odds of CKD. Higher sodium intake was associated with higher odds of CKD (OR, 1.21; 95% CI, 1.06 to 1.38; I2=59%; evidence quality: moderate) (Figure 1, Table 1). Meta-analysis of studies evaluating carbohydrate intake, fish, fruit, phosphorus, protein, and sugar-sweetened beverages consumption showed no clear association (Table 1).
Table 1. -
Meta-analyses performed in the review showing the association of
alcohol consumption,
diet, physical activity, and
smoking exposure with the risk of incident CKD
| Exposure |
Studies |
Participants |
Association Ratio [95% CI] |
Heterogeneity I
2, % |
Evidence Quality
a
|
| Diet factors |
|
|
|
|
|
| Fish |
3 |
21,226 |
OR, 0.94 [0.86 to 1.02] |
5 |
Low |
| Fruit |
4 |
28,779 |
OR, 0.91 [0.79 to 1.06] |
60 |
Very low |
| Vegetables |
5 |
32,054 |
OR, 0.79 [0.70 to 0.90] |
57 |
Low |
| Sugar-sweetened beverages |
4 |
22,760 |
OR, 1.45 [0.97 to 2.15] |
68 |
Very low |
| Carbohydrates |
3 |
20,238 |
OR, 1.08 [0.85 to 1.36] |
63 |
Very low |
| Protein |
3 |
19,835 |
OR, 1.08 [0.91 to 1.28] |
47 |
Very low |
| Phosphorus |
3 |
23,466 |
OR, 1.00 [0.75 to 1.32] |
72 |
Very low |
| Potassium |
7 |
32,647 |
OR, 0.78 [0.65 to 0.94] |
48 |
Low |
| Sodium |
6 |
43,772 |
RR, 1.21 [1.06 to 1.38] |
59 |
Moderate |
| Physical activity |
|
|
|
|
|
| High versus low levels |
9 |
70,828 |
RR, 0.82 [0.69 to 0.98] |
83 |
Very low |
| Alcohol consumption |
|
|
|
|
|
| High versus low intakes |
13 |
216,291 |
RR, 0.87 [0.79 to 0.95] |
43 |
Low |
| Moderate versus low intakes |
7 |
165,415 |
RR, 0.86 [0.79 to 0.93] |
50 |
Moderate |
| Tobacco smoking |
|
|
|
|
|
| Never versus former |
6 |
944,931 |
OR, 1.09 [1.01 to 1.17] |
90 |
Very low |
| Current or former versus never |
12 |
985,086 |
OR, 1.18 [1.10 to 1.27] |
81 |
Very low |
aSummary of findings, which details the reasons for downgrading evidence quality, is reported in
Supplemental Table 7.
;)
Figure 1.: There was a reduced odds of CKD in people who were exposed to a higher vegetable intake and potassium intake and an increased odds of CKD in people who were exposed to a higher sodium intake. Association of (A) vegetable intake, (B) potassium intake, (C) sodium intake, and incident CKD. Note that the association estimate for each lifestyle factor is presented on the ratio (OR or RR) that was predominantly used in the included studies. IV, inverse variance.
We were unable to pool data on 32 additional dietary factors reported across 21 studies (Supplemental Table 4).15,16,18,19,23,25,27,30–32,37,45–47,57,59–62,71,73 We identified 19 dietary factors for which one or both available studies showed an association in the direction indicating decreased risk: cereal fiber, coffee, dairy, fiber, folate, legumes, magnesium, nitrate, nuts, nuts and legumes, plant protein, omega-3, DHA, EPA, vitamin B12, vitamin C, vitamin D, vitamin E, and zinc. We identified two dietary factors for which one or both available studies indicated a harmful relationship: a higher sodium-potassium ratio and red and processed meat consumption (Supplemental Table 4).
Physical Activity
The association of different levels of physical activity with incident CKD was described in ten studies of 78,301 participants (Figure 2, Table 1).28,34,42,44,53,54,58,59,63,72 Meta-analysis of nine studies showed lower odds of CKD in people who were more physically active compared with those who were less physically active (OR, 0.82; 95% CI, 0.69 to 0.98; I2=83%; evidence quality: very low).
Figure 2.: There is a significant reduced odds of incident CKD from increased levels of physical activity.
Alcohol Intake
The association between alcohol intake and incident CKD was described in 14 studies of 211,072 participants.22,23,28,40,43,50,52,55,63–65,67,68,72 Compared with lower intakes, meta-analysis showed that higher consumption of alcohol (RR, 0.87; 95% CI, 0.79 to 0.95; I2=43%; evidence quality: low) and moderate alcohol consumption (RR, 0.86; 95% CI, 0.79 to 0.93; I2=50%; evidence quality: moderate) were associated with lower risk of CKD (Figure 3, Table 1). In a dose-response metaregression analysis, we modeled the relationship between incident CKD and alcohol intake using restricted cubic splines (Supplemental Figure 3, Supplemental Table 5) and found that higher alcohol intake was associated with lower risk of incident CKD. This association was generally observed throughout the whole range of alcohol consumption considered with a significant effect size (P values for nonlinearity =0.03). There was no apparent association when people who had never consumed alcohol were compared with those who had consumed it in the past (former intake) (Table 1).
Figure 3.: There was a reduced risk of CKD in people who has a higher alcohol consumption and an increased odds of CKD in people who were exposed to higher tobacco smoking. Association of (A) alcohol consumption, (B) tobacco smoking, and incident CKD. Note that the association estimate for each lifestyle factor is presented on the ratio (OR or RR) that was predominantly used in the included studies. IV, inverse variance.
Smoking
The association between smoking and incident CKD was described in 12 studies of 985,086 participants.28,29,35,43,50,52,53,59,63,65,68,74 Compared with people who never smoked, current and former smokers (ever smokers) showed higher odds of CKD (OR, 1.18; 95% CI, 1.10 to 1.27; I2=81%; evidence quality: very low) (Figure 3, Table 1). Compared with people who had never smoked, former smokers had increased odds of CKD (OR, 1.09; 95% CI, 1.01 to 1.17; I2=90%; evidence quality: very low) in six studies of 944,931 participants (Table 1). There was no consistent association with CKD in two studies comparing current with former smokers (Supplemental Table 4).
Lifestyle Risk Factors and Secondary Outcomes (RRT, GFR Decline, and Albuminuria)
The consistency of associations between the lifestyle factors identified in our primary analysis and other markers of kidney damage is shown in Figure 4.
Figure 4.: The association of vegetable intake, potassium intake, physical activity, alcohol consumption, sodium intake, and tobacco smoking was consistent across incident CKD and KRT, however had varying association to GFR decline and albuminuria. NA, not applicable. aThe four studies of sodium intake and GFR decline were not meta-analyzable because two of the studies reported means and variance but not ratio data.
The association between lifestyle factors and RRT was described in 17 studies of 990,723 participants.33,35,37,75–88 The association between lifestyle factors and GFR decline was described in 32 studies of 108,936 participants,14,20,23,34,46,49,73,86,89–105 and the association between lifestyle factors and albuminuria was described in 20 studies of 512,403 participants.23,39,41,88,95,100,101,105–116Table 2 and Supplemental Material have the details. The risk of RRT was higher among current and former smokers (RR, 1.59; 95% CI, 1.30 to 1.94; I2=68%; evidence quality: moderate) compared with never smokers (Supplemental Figure 4). The risk of GFR decline was lower in persons with higher potassium intake (RR, 0.49; 95% CI, 0.31 to 0.79; I2=90%; evidence quality: very low) and those who were physically active (OR, 0.76; 95% CI, 0.59 to 0.97; I2=75%; evidence quality: very low) (Supplemental Figure 5). The risk of albuminuria was lower among physically active persons (OR, 0.88; 95% CI, 0.81 to 0.96; I2=0%; evidence quality: low) and higher among tobacco smokers (OR, 1.67; 95% CI, 1.23 to 2.26; I2=88%; evidence quality: very low) (Supplemental Figure 6).
Table 2. -
Meta-analyses performed in the review showing the association of
alcohol consumption,
diet, physical activity, and
smoking exposure with secondary outcomes (RRT, GFR decline, and albuminuria)
| Exposure |
Studies |
Participants |
Association Ratio [95% CI] |
Heterogeneity I
2, % |
Evidence Quality
a
|
| RRT
b
|
|
|
|
|
|
| Tobacco smoking |
|
|
|
|
|
| Former versus current |
7 |
1,126,913 |
RR, 1.25 [1.13 to 1.39] |
39 |
Moderate |
| Current or former versus never |
8 |
1,230,390 |
RR, 1.59 [1.30 to 1.94] |
68 |
Moderate |
| GFR decline
c
|
|
|
|
|
|
| Diet factors |
|
|
|
|
|
| Potassium |
4 |
10,729 |
RR, 0.49 [0.31 to 0.79] |
81 |
Very low |
| Protein |
5 |
18,507 |
OR, 1.07 [0.96 to 1.19] |
42 |
Low |
| Physical activity |
|
|
|
|
|
| High versus low levels |
5 |
15,161 |
OR, 0.77 [0.63 to 0.93] |
75 |
Very low |
| Alcohol consumption |
|
|
|
|
|
| High versus low intakes |
5 |
16,580 |
OR, 0.88 [0.72 to 1.07] |
15 |
Very low |
| Albuminuria |
|
|
|
|
|
| Diet factors |
|
|
|
|
|
| Sodium |
3 |
11,751 |
OR, 1.01 [0.89 to 1.14] |
0 |
Very low |
| Physical activity |
|
|
|
|
|
| High versus low levels |
4 |
110,154 |
RR, 0.88 [0.81 to 0.96] |
0 |
Low |
| Alcohol consumption |
|
|
|
|
|
| High versus low intakes |
7 |
220,479 |
RR, 1.03 [0.88 to 1.20] |
59 |
Low |
| Tobacco smoking |
|
|
|
|
|
| Current or former versus never |
7 |
184,302 |
OR, 1.67 [1.23 to 2.26] |
88 |
Very low |
aSummary of findings, which details the reasons for downgrading evidence quality, is reported in
Supplemental Table 7.
bMeta-analysis was not possible for diet factors, physical activity, or alcohol consumption.
cMeta-analysis was not possible for tobacco smoking.
Other lifestyle hazards did not have sufficient studies to allow meta-analysis, but their associations suggested that they may be potentially protective, be potentially harmful, or have no association to secondary study outcomes on the basis of the direction of the majority (≥50%) of studies. Results are shown in Supplemental Figure 7 and fully detailed in Supplemental Tables 3 and 4. In brief, coffee consumption was associated with lower risk of incident CKD and RRT in two of two and one of two studies, respectively. Dairy intake was associated with lower risk of incident CKD and albuminuria in two of four and one of two studies, respectively. Red and processed meats were associated with lower risk of incident CKD, RRT, and albuminuria in one of two, one of one, and one of one studies, respectively.
Subgroup and Sensitivity Analyses
Subgroup analyses did not show consistent relationships with duration of exposure or geographic region. Replacing individual datasets (substituting alternative reports from the same cohort) did not meaningfully change results (Supplemental Material). We also conducted a post hoc sensitivity analysis on the way that the frequency of alcohol consumption was reported: higher “daily” consumption of alcohol had no significant association with incident CKD (seven studies; RR, 0.98; 95% CI, 0.82 to 1.18; I2=43%), whereas higher weekly alcohol consumption was associated with a lower risk of incident CKD (six studies; RR, 0.82; 95% CI, 0.75 to 0.90; I2=32%) (Supplemental Table 6). Subgroup analysis was conducted to compare studies with participants with baseline GFR ≥89.9–70 ml/min per 1.73 to participants with GFR≥90 ml/min per 1.73 and showed significant associations between study exposures (except for physical activity) and the risk of incident CKD in studies with participants baseline GFR ≥89.9–70 ml/min per 1.73. The association of vegetable intake and incident CKD was robust in both baseline GFR subgroups. Whereas in studies reporting participant baseline GFR ≥90 ml/min per 1.73 (which were 37 of 104; 12 studies were able to be meta-analyzed), these associations did not attain statistical significance. However, the direction and magnitude of observed risks in both strata were very similar (Supplemental Table 6).
Quality Assessment
The certainty (GRADE) of the evidence for each outcome meta-analyzed is detailed in Supplemental Table 8. The overall risk of bias across the studies was low (Supplemental Figures 8 and 9). Eighty-eight percent of studies had a low risk of bias for sample, whereas 10% were rated high due to being conducted in populations with established diseases (such as type 2 diabetes or hypertension) that are known to increase the risk of incident CKD. With respect to follow-up, 82% of studies had low risk of bias, and bias was judged unclear in 13% of studies that reported <4 years of follow-up; three studies (5%) had a high risk of bias due to very short follow-up periods of <2 years. The risk of bias in the "exposure" domain was rated high in 92% of studies because lifestyle behaviors were self-reported; objective measures were used in eight studies (8%). Outcomes were captured using appropriate tools (and rated low risk) in 88% of studies, and rated high risk in 6% of the studies. Potential analysis bias was low in 73% of studies, where 23% were unclear because data were not analyzed using ratio statistics to allow statistically data pooling.
Discussion
This study evaluated the association between modifiable lifestyle factors and incident CKD in the community. In predominately low- to very low–certainty evidence, we found higher intake of potassium and vegetables, lower intake of sodium, physical activity, moderate alcohol consumption, and avoidance of tobacco smoking to be consistently associated with lower risk of CKD. We identified consistency with these main results when we examined their association with other surrogates of kidney damage: RRT, GFR decline, and albuminuria.
Higher vegetable intake is associated with higher potassium intake: both dietary factors were consistently associated with fewer kidney outcomes. Low vegetable consumption is a strong predictor of mortality in the general population.117,118 The mechanism is likely, at least in part, through the intermediary diseases that are themselves risks for CKD: cardiovascular disease, hypertension, diabetes, obesity, and metabolic syndrome.119 Whether there is additionally a more direct relationship between vegetable or potassium intake and kidney health requires further study.
In our analysis, higher potassium intake was associated with reduced incident CKD and GFR decline, adding to the growing evidence base for the protective association of potassium intake in other chronic conditions. In the Prospective Urban Rural Epidemiology study, higher potassium excretion was associated with a lower risk of death and cardiovascular events across >18 countries worldwide.120 Higher intakes of potassium have also been demonstrated to lower the risk of stroke121 and lower BP in adults with and without hypertension.122,123 In patients in the ONTARGET, a high-vascular risk cohort (most of whom did not have CKD at baseline), potassium intake was associated with a less rapid GFR decline or need for RRT.124 In ONTARGET, the relationship between potassium intake and the outcome did not seem to differ by baseline level of albuminuria, but there was a statistically significant interaction suggesting that the protective association with potassium might not be observed in patients with GFR<45 ml/min (advanced CKD). In these patients, potassium and with it, fruits and vegetables are often restricted. When discussing dietary advice, it is critical to distinguish whether we are concerned with prevention of incident CKD, prevention of progression (and at what level of GFR), or management of hyperkalemia and management of the risk of hyperkalemia.125
Similarly, higher sodium intake showed a consistent association with increased risk of incident CKD, RRT, and GFR decline. This supports the growing evidence from clinical trials demonstrating the effect of sodium intake on BP, proteinuria, and extracellular volume in CKD.126 Despite existing controversy surrounding reverse causality at extremely low sodium intakes,127 our review supports the message that higher sodium intakes are detrimental, and public health efforts should be prioritized to reduce population-wide sodium consumption. More work is needed on the optimal level of sodium restriction; our analysis focused on high versus low intake, but in the original studies, the highest exposures of salt defining high intake varied, ranging from ≥9.88 to 16.27 g/d (sodium ≥172–283 mmol/d).
A healthy diet pattern, characterized by higher intake of fruit, vegetables, low-fat dairy, fiber, and whole grains and lower intake of sodium, red meat, and sugar, has been associated with a 30% reduced odds of kidney damage.11,12 Many of the individual diet factors we identified are characteristic of a higher diet quality and overall healthier diet pattern. For example, taking all of the data into account, diet factors possibly protective against incident CKD in our study included fruit, dairy, vegetables, fiber, legumes, nuts, potassium, and unsaturated fatty acids. In contrast, diet factors possibly harmful to incident CKD in our study included excessive carbohydrate intake, high energy intake, red and processed meats, saturated fat, sodium, sodium-potassium ratio, and sugar-sweetened beverages. The protective factors, characteristics of a healthy diet, are also strongly associated with reduced risk of overweight and obesity,128 which are linked with increased risk of incident CKD.129 These associations fundamentally align with guidelines for general healthy eating and cardiovascular disease prevention, which is helpful and convenient in guiding public health policy for CKD prevention that aligns with prevention of other chronic diseases.130
We found that higher levels of physical activity were consistently associated with a lower risk of all study outcomes evaluated. This aligns with the majority of existing studies, which suggest that physical activity is associated with reduced risk of kidney damage through attenuating cardiovascular disease risk,131,132 mortality,133 and rapid declines in kidney function.134 Whether a relationship independent of cardiovascular and vascular damage truly exists is not known on the basis of current data. Possible mechanisms include reduced BP, improved glycemic control, angiogenesis, and vascular regeneration by the upregulation of endothelial nitric oxide production and other antioxidant enzymes.135 Although the measurement of physical activity was heterogeneous across the included studies, the most common categorization of higher levels of activity was defined as at least 30 minutes a day.44,59 These findings suggest that public health messages should emulate those of primary prevention of cardiovascular disease: to achieve and maintain a moderate level of physical activity of at least 30 minutes a day and avoid extended periods of being sedentary.136,137
We found an inverse association between alcohol consumption and incident CKD, RRT, and GFR decline. Although the relationship between alcohol consumption and kidney function decline has not been consistent in the current body of literature, many clinical studies have indeed shown that moderate alcohol consumption is associated with lower occurrence of CKD.40,55,64,68 In contrast, existing literature has shown that chronic alcoholism is associated with CKD,56,65 leading to the hypothesis that excessive alcohol consumption directly damages the kidney, independent of liver damage.138,139 Similarly, some reports included in our review found that heavy drinking, in contrast with moderate drinking, was associated with increased risk of albuminuria and CKD.56,105,140 This distinction (that moderate, but not high, alcohol consumption is associated with lower prevalence of albuminuria and CKD compared with abstinence or with lower intakes) is consistent with a number of other studies.139,141,142 There is also the possibility that unadjusted confounders may be at play: for example, social integration as a product of moderate alcohol consumption and overall well-being, which is good for health.143 It would seem, despite minor international variations144 and the heterogenous categorization for the higher alcohol consumption (ranging in grams per day [range, 20–48 g/d], grams per week [range, 210 g/wk], total drinks per day [range, >1–4 drinks per day], and drinks per week [range, 5–>15 drinks per week]), that moderate alcohol consumption in line with public health guidelines seems safe and unlikely to cause kidney damage in the general population.
Current and former smokers had higher risk of incident CKD compared with those who never smoked. Tobacco smoking has been previously identified as a risk factor for incident CKD and RRT in the general population.145 Although the mechanism is uncertain, smoking may lead to insulin resistance,146 which might explain the large effect size (67% increase in risk) of smoking on risk of albuminuria observed in our study, consistent with previous observations.147 The harmful effects of smoking may also be mediated by endothelial cell dysfunction, inducing advanced glycation end products due to glycotoxins present in cigarettes, increased vascular permeability and pathologic vascular changes of kidney disease, and insulin resistance in diabetic and nondiabetic subjects.145 Taken together, these risk factors for kidney function decline clearly support a public health message to avoid tobacco smoking to prevent kidney disease as well as cardiovascular disease.
This study has strengths as the first evidence synthesis of lifestyle risk and protective factors and primary prevention of CKD: it is broad in scope, and we have taken a rigorous approach to meta-analysis. However, this study has limitations. First, there was scarce evidence for some exposures, particularly for diet factors, precluding meta-analysis; for these factors, our output is simply descriptive. Second, there was variation in the definition of the different exposures across the different lifestyle factors, in the degree of adjustment for potential confounders, and in definition and reporting for study outcomes. For example, there were no consistent adjustments for activity, age, education, and sex (as reported in Supplemental Table 3) in all studies included in the analyses. Furthermore, ten different definitions of incident CKD were used in the included studies, with similar heterogeneity in the definitions of the secondary outcomes. This leads to heterogeneity in the analysis and precludes clear recommendations in terms of possible targets, goals, or thresholds. Third, although we were able to perform meta-analysis to account for the known nonlinear associations of alcohol consumption and kidney outcomes, we were unaware of any such assumptions for the other lifestyle factors, and the original studies did not commonly report their associations in this way. The original papers usually made a linear assumption and analyzed data with linear models. It is possible that nonlinear effects or threshold effects may be missed in this way. Fourth, because we evaluated cohort studies and not randomized trials, the findings do not imply causality. However, there were no trials of this nature in our search, and it is unlikely that studies of sufficient rigor, size, and duration will be conducted, given the resource-intensive nature of such trials. We combined RR and OR; for rare events, these are numerically similar, although calculated differently. Fifth, we used the NOS to assess bias rather than the more comprehensive ROBINS-I tool148 because our resources to complete the study were finite. Finally, in order to conduct meta-analysis, each putative risk and protective factor was considered separately, and we do not know whether there are quantitatively important interactions between the different factors (e.g., does the effect of carbohydrate intake differ at different levels of physical activity), as no study has evaluated such hypotheses.
Allowing for the limitations of inferences from observational studies, our work suggests that the lifestyle factors that we have evaluated are probably those that patients have the most control over. However, these should not be the only ones that public health authorities target. For example, other potentially modifiable hazards known to increase the risk of kidney damage include environmental pollution,149,150 excessive body weight related to nutrition,129 inappropriate use of medications (including analgesics, antibiotics, antiretrovirals, or proton-pump inhibitors),151 and heavy metal exposure and intake (in particular, cadmium).152 Finally, society has a further role to play in facilitating more personal choices through food labeling, alcohol and tobacco labeling, health policy around exercise, policy around the ease of walking and cycling in the built environment, and walkability.
We recognize that these findings are on the basis of nonrandomized data with risk of residual and unknown confounding, particularly in the setting of studies with low to very low certainty of the evidence. However, the generalizability and overall importance of these findings should not be undermined, as they are well in line with public health recommendations for preventing related chronic conditions and general healthy lifestyle principles. Therefore, the results can represent important indications for public policy and advocacy and be hypothesis generating for future randomized trials. It is not trivial to ask patients to change their lifestyle. Diet, in particular, is a highly social and cultural issue; furthermore, many patients are constrained by external factors, including economic factors, in their decisions. For these reasons, we believe that lifestyle intervention studies to address unanswered questions examining the whole range of clinically important outcomes, including the incidence and progression of CKD, continue to be justified.
Increased vegetable and potassium intake, physical activity, and moderate alcohol consumption were consistently associated with reduced risk of CKD. Increased dietary salt intake and tobacco smoking were consistently associated with increased risk of CKD. In the absence of trial evidence, these findings can inform both public health recommendations and patient-centered discussions in clinical practice.
Disclosures
K. Campbell has received consultation, advisory board membership, or research funding from the Dietitians Association of Australia, Nestle Health Sciences, and Queensland Health, all outside the submitted work. J.J. Carrero reports grant funding from Astellas, AstraZeneca, Vetenskapsrådet (2019-01059), and ViforPharma; consulting for AstraZeneca and Baxter; speaker fees for Abbott, AstraZeneca, Fresenius, Nutricia, and ViforPharma; and support from the Swedish Heart and Lung Foundation, all outside the submitted work. C.M. Clase has received consultation, advisory board membership, or research funding from Amgen, Astellas, AstraZeneca, Baxter, Boehringer-Ingelheim, Fresenius Medical Care, Janssen, Johnson & Johnson, Leo Pharma, the Ontario Ministry of Health, Pfizer, Relyspa, Sanofi, and Vifor, all outside the submitted work. J.T. Kelly has received consultancy fees from Amgen for travel and lecture presentations and consultancy fees from HealthCert for topics unrelated to the submitted work. J.T. Kelly is supported through a Griffith University Postdoctoral Research Fellowship, outside the submitted work. A. González-Ortiz is supported by School of Medicine, Programa de Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Consejo Nacional de Ciencia y Tecnología grant CVU 373297, outside the submitted work. G. Su is supported by the European Renal Association-European Dialysis and Transplantation Association Young Fellowship Programme and by Guangdong Provincial Hospital of Traditional Chinese Medicine grant YN2018QL08, outside the submitted work. H. Xu is supported by Loo and Hans Osterman’s Foundation, outside the submitted work. All remaining authors have nothing to disclose.
Funding
None.
Prof. Juan J. Carrero and Dr. Jaimon Kelly contributed to the study conception; Ms. Ailema González-Ortiz, Dr. Jaimon Kelly, Dr. Skye Marshall, Dr. Xindong Qin, Dr. Guobin Su, Dr. Hong Xu, and Dr. La Zhang conducted the literature search, extracted data, and appraised risk of bias; Dr. Jaimon Kelly conducted the data analysis; Dr. Jaimon Kelly was responsible for writing the first draft of the manuscript; Prof. Juan J. Carrero reviewed the first draft of the manuscript; Dr. Katrina Campbell and Dr. Catherine M. Clase critically reviewed the manuscript; and all authors read and approved the final version of the manuscript.
This work is endorsed and performed within the European Renal Nutrition working group, an initiative of and supported by the European Renal Association-European Dialysis and Transplantation Association.
Supplemental Material
This article contains the following supplemental material online at http://jasn.asnjournals.org/lookup/suppl/doi:10.1681/ASN.2020030384/-/DCSupplemental.
Supplemental Figure 1. Study flow diagram.
Supplemental Figure 2. Summary of the associations between modifiable lifestyle risk and protective factors and risk of incident CKD.
Supplemental Figure 3. Dose-response relationship between alcohol intake (grams per day) and incident CKD estimated with a random effect metaregression-restricted cubic spline model.
Supplemental Figure 4. Association of tobacco smoking and ESKD.
Supplemental Figure 5. Summary of the associations between modifiable lifestyle risk and protective factors and risk of GFR decline.
Supplemental Figure 6. Summary of the associations between modifiable lifestyle risk and protective factors and risk of albuminuria.
Supplemental Figure 7. Consistency of associations in lifestyle factors that could not be statistically pooled across the markers of kidney function decline.
Supplemental Figure 8. Risk of bias across the included studies.
Supplemental Figure 9. Individual assessment of risk of bias across the included studies.
Supplemental Figure 10. Funnel plots for lifestyle hazards and incident CKD.
Supplemental Figure 11. Funnel plots for lifestyle hazards and secondary outcomes.
Supplemental Material. Data synthesis for secondary outcomes.
Supplemental Table 1. Search terms used across the electronic databases.
Supplemental Table 2. Summary of the methods relating to data extraction, risk of bias, metaregression, and planned subgroup and sensitivity analyses.
Supplemental Table 3. Characteristics of the included studies.
Supplemental Table 4. Lifestyle hazards and kidney disease outcomes from individual studies that could not be statistically pooled into meta-analysis.
Supplemental Table 5. Summary of the studies between alcohol intake and incident CKD.
Supplemental Table 6. Subgroup analysis for incident CKD.
Supplemental Table 7. Results from sensitivity analysis.
Supplemental Table 8. GRADE table summarizing the quality of the evidence for each outcome.
References
1. Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, et al.: Assessment of global kidney health care status. JAMA 317: 1864–1881, 2017 28430830
2. GBD
Chronic Kidney Disease Collaboration: Global, regional, and national burden of
chronic kidney disease, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 395: 709–733, 2020 32061315
3. Bello A, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, et al.; Global Kidney Health Atlas: A Report by the International Society of Nephrology on the Current State of Organization and Structures for Kidney Care across the Globe, Brussels, Belgium, International Society of Nephrology, 2017
4. Kelly JT, Campbell KL, Carrero JJ: Primary versus secondary prevention of
chronic kidney disease: The case of dietary protein. J Ren Nutr 28: 225–228, 2018 29935606
5. Åkesson A, Weismayer C, Newby PK, Wolk A: Combined effect of low-risk dietary and
lifestyle behaviors in primary prevention of myocardial infarction in women. Arch Intern Med 167: 2122–2127, 2007 17954808
6. Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB: Primary prevention of stroke by healthy
lifestyle. Circulation 118: 947–954, 2008 18697819
7. Chiuve SE, Fung TT, Rexrode KM, Spiegelman D, Manson JE, Stampfer MJ, et al.: Adherence to a low-risk, healthy
lifestyle and risk of sudden cardiac death among women. JAMA 306: 62–69, 2011 21730242
8. World Health Organization: Global Status Report on Noncommunicable Diseases 2014, Geneva, Switzerland, World Health Organization, 2014
9. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al.: Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008–2012, 2000 10789670
10. Kidney Disease: Improving Global Outcomes (KDIGO): CKD evaluation and management. 2012. Available at:
https://kdigo.org/guidelines/ckd-evaluation-and-management/. Accessed February 19, 2020
11. Bach KE, Kelly JT, Palmer SC, Khalesi S, Strippoli GFM, Campbell KL: Healthy dietary patterns and incidence of CKD: A meta-analysis of cohort studies. Clin J Am Soc Nephrol 14: 1441–1449, 2019 31551237
12. van Westing AC, Küpers LK, Geleijnse JM:
Diet and kidney function: A literature review. Curr Hypertens Rep 22: 14, 2020 32016564
13. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al.: Newcastle-Ottawa Quality Assessment Scale Cohort Studies, Ottawa, Ontario, Canada, Ottawa Hospital Research Institute, 2014
14. Araki S, Haneda M, Koya D, Kondo K, Tanaka S, Arima H, et al.: Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function. Clin J Am Soc Nephrol 10: 2152–2158, 2015 26563378
15. Asghari G, Yuzbashian E, Mirmiran P, Azizi F: The association between Dietary Approaches to Stop Hypertension and incidence of
chronic kidney disease in adults: The Tehran Lipid and Glucose Study. Nephrol Dial Transplant 32[Suppl 2]: ii224-ii230, 2017 28201810
16. Asghari G, Yuzbashian E, Shahemi S, Gaeini Z, Mirmiran P, Azizi F: Dietary total antioxidant capacity and incidence of
chronic kidney disease in subjects with dysglycemia: Tehran Lipid and Glucose Study. Eur J Nutr 57: 2377–2385, 2018 28741082
17. Baggio B, Budakovic A, Perissinotto E, Maggi S, Cantaro S, Enzi G, et al.; ILSA Working Group: Atherosclerotic risk factors and renal function in the elderly: The role of hyperfibrinogenaemia and
smoking. Results from the Italian Longitudinal Study on Ageing (ILSA). Nephrol Dial Transplant 20: 114–123, 2005 15572387
18. Bahadoran Z, Mirmiran P, Ghasemi A, Carlström M, Azizi F, Hadaegh F: Association between dietary intakes of nitrate and nitrite and the risk of hypertension and
chronic kidney disease: Tehran Lipid and Glucose Study. Nutrients 8: 811, 2016 28009811
19. Bahadoran Z, Mirmiran P, Golzarand M, Davudabadi-Farahani R, Azizi F: Dietary animal-derived L-arginine intakes and risk of
chronic kidney disease: A 6-year follow-up of Tehran Lipid and Glucose Study. Iran J Kidney Dis 11: 352–359, 2017 29038390
20. Bahadoran Z, Mirmiran P, Momenan AA, Azizi F: Allium vegetable intakes and the incidence of cardiovascular disease, hypertension,
chronic kidney disease, and type 2 diabetes in adults: A longitudinal follow-up study. J Hypertens 35: 1909–1916, 2017 28319598
21. Bomback AS, Derebail VK, Shoham DA, Anderson CA, Steffen LM, Rosamond WD, et al.: Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int 77: 609–616, 2010 20032963
22. Buja A, Scafato E, Baggio B, Sergi G, Maggi S, Rausa G, et al.: Renal impairment and moderate
alcohol consumption in the elderly. Results from the Italian Longitudinal Study on Aging (ILSA). Public Health Nutr 14: 1907–1918, 2011 21729477
23. Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, et al.; ONTARGET Investigators:
Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med 173: 1682–1692, 2013 23939297
24. Dunkler D, Kohl M, Teo KK, Heinze G, Dehghan M, Clase CM, et al.: Dietary risk factors for incidence or progression of
chronic kidney disease in individuals with type 2 diabetes in the European Union. Nephrol Dial Transplant 30[Suppl 4]: iv76-iv85, 2015 26209742
25. Ejtahed HS, Angoorani P, Asghari G, Mirmiran P, Azizi F: Dietary advanced glycation end products and risk of
chronic kidney disease. J Ren Nutr 26: 308–314, 2016 27373588
26. Farhadnejad H, Asghari G, Emamat H, Mirmiran P, Azizi F: Low-carbohydrate high-protein
diet is associated with increased risk of incident chronic kidney diseases among Tehranian adults. J Ren Nutr 29: 343–349, 2019 30579675
27. Farhadnejad H, Asghari G, Mirmiran P, Yuzbashian E, Azizi F: Micronutrient intakes and incidence of
chronic kidney disease in adults: Tehran Lipid and Glucose Study. Nutrients 8: 217, 2016 27104561
28. Foster MC, Hwang S-J, Massaro JM, Jacques PF, Fox CS, Chu AY:
Lifestyle factors and indices of kidney function in the Framingham Heart Study. Am J Nephrol 41: 267–274, 2015 25998023
29. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844–850, 2004 14970063
30. Gopinath B, Harris DC, Flood VM, Burlutsky G, Brand-Miller J, Mitchell P: Carbohydrate nutrition is associated with the 5-year incidence of
chronic kidney disease. J Nutr 141: 433–439, 2011 21228263
31. Gopinath B, Harris DC, Flood VM, Burlutsky G, Mitchell P: Associations between dairy food consumption and
chronic kidney disease in older adults. Sci Rep 6: 39532, 2016 27996057
32. Haring B, Selvin E, Liang M, Coresh J, Grams ME, Petruski-Ivleva N, et al.: Dietary protein sources and risk for incident
chronic kidney disease: Results from the Atherosclerosis Risk in Communities (ARIC) Study. J Ren Nutr 27: 233–242, 2017 28065493
33. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J: Risk factors for
chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14: 2934–2941, 2003 14569104
34. Hawkins M, Newman AB, Madero M, Patel KV, Shlipak MG, Cooper J, et al.: TV watching, but not physical activity, is associated with change in kidney function in older adults. J Phys Act Health 12: 561–568, 2015 24762526
35. Hippisley-Cox J, Coupland C: Predicting the risk of
chronic kidney disease in men and women in England and Wales: Prospective derivation and external validation of the QKidney scores. BMC Fam Pract 11: 49, 2010 20565929
36. Hu EA, Lazo M, Rosenberg SD, Grams ME, Steffen LM, Coresh J, et al.:
Alcohol consumption and incident kidney disease: Results from the atherosclerosis risk in communities study. J Ren Nutr 30: 22–30, 2020 30850190
37. Hu EA, Selvin E, Grams ME, Steffen LM, Coresh J, Rebholz CM: Coffee consumption and incident kidney disease: Results from the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 72: 214–222, 2018 29571833
38. Jhee JH, Kee YK, Park JT, Chang TI, Kang EW, Yoo TH, et al.: A
diet rich in vegetables and fruit and incident CKD: A community-based prospective cohort study. Am J Kidney Dis 74: 491–500, 2019 31040089
39. Kieneker LM, Bakker SJ, de Boer RA, Navis GJ, Gansevoort RT, Joosten MM: Low potassium excretion but not high sodium excretion is associated with increased risk of developing
chronic kidney disease. Kidney Int 90: 888–896, 2016 27575557
40. Koning SH, Gansevoort RT, Mukamal KJ, Rimm EB, Bakker SJ, Joosten MM; PREVEND Study Group:
Alcohol consumption is inversely associated with the risk of developing
chronic kidney disease. Kidney Int 87: 1009–1016, 2015 25587707
41. Lee CC, Howard BV, Mete M, Wang H, Jolly S, Adler AI: Association between fish consumption and nephropathy in American Indians—the Strong Heart study. J Ren Nutr 22: 221–227, 2012 21742515
42. Lin H-C, Peng C-H, Chiou J-Y, Huang C-N: Physical activity is associated with decreased incidence of
chronic kidney disease in type 2 diabetes patients: A retrospective cohort study in Taiwan. Prim Care Diabetes 8: 315–321, 2014 24815574
43. Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, Tanaka H, et al.: The association between changes in
lifestyle behaviors and the incidence of
chronic kidney disease (CKD) in middle-aged and older men. J Epidemiol 27: 389–397, 2017 28385348
44. Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, Tanaka H, et al.: The joint impact of habitual
exercise and glycemic control on the incidence of
chronic kidney disease (CKD) in middle-aged and older males. Environ Health Prev Med 22: 76, 2017 29165174
45. Mirmiran P, Bahadoran Z, Golzarand M, Asghari G, Azizi F: Consumption of nitrate containing vegetables and the risk of
chronic kidney disease: Tehran Lipid and Glucose Study. Ren Fail 38: 937–944, 2016 27055566
46. Mirmiran P, Nazeri P, Bahadoran Z, Khalili-Moghadam S, Azizi F: Dietary sodium to potassium ratio and the incidence of
chronic kidney disease in adults: A longitudinal follow-up study. Prev Nutr Food Sci 23: 87–93, 2018 30018885
47. Mirmiran P, Yuzbashian E, Asghari G, Sarverzadeh S, Azizi F: Dietary fibre intake in relation to the risk of incident
chronic kidney disease. Br J Nutr 119: 479–485, 2018 29352819
48. Miyatake N, Moriyasu H, Sakano N, Tada S, Suzue T, Hirao T: Influence of cigarette
smoking on estimated glomerular filtration rate (eGFR) in Japanese male workers. Acta Med Okayama 64: 385–390, 2010 21173808
49. Mun KH, Yu GI, Choi BY, Kim MK, Shin MH, Shin DH: Association of dietary potassium intake with the development of
chronic kidney disease and renal function in patients with mildly decreased kidney function: The Korean Multi-Rural Communities cohort study. Med Sci Monit 25: 1061–1070, 2019 30733429
50. Nakanishi N, Fukui M, Tanaka M, Toda H, Imai S, Yamazaki M, et al.: Low urine pH Is a predictor of
chronic kidney disease. Kidney Blood Press Res 35: 77–81, 2012 21912182
51. Nam KH, An SY, Joo YS, Lee S, Yun HR, Jhee JH, et al.: Carbohydrate-rich
diet is associated with increased risk of incident
chronic kidney disease in non-diabetic subjects. J Clin Med 8: 793, 2019 31167515
52. Noborisaka Y, Ishizaki M, Yamada Y, Honda R, Yokoyama H, Miyao M, et al.: The effects of continuing and discontinuing
smoking on the development of
chronic kidney disease (CKD) in the healthy middle-aged working population in Japan. Environ Health Prev Med 18: 24–32, 2013 22623223
53. Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, et al.: Predictors of new-onset decline in kidney function in a general middle-European population. Nephrol Dial Transplant 23: 1265–1273, 2008 18039642
54. Ogunmoroti O, Allen NB, Cushman M, Michos ED, Rundek T, Rana JS, et al.: Association between life’s simple 7 and noncardiovascular disease: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 5: e003954, 2016 27792654
55. Okada Y, Uehara S, Shibata M, Koh H, Oue K, Kambe H, et al.: Habitual
alcohol intake modifies relationship of uric acid to incident
chronic kidney disease. Am J Nephrol 50: 55–62, 2019 31170706
56. Pan CS, Ju TR, Lee CC, Chen YP, Hsu CY, Hung DZ, et al.:
Alcohol use disorder tied to development of
chronic kidney disease: A nationwide database analysis. PLoS One 13: e0203410, 2018 30188943
57. Park I, Xun P, Tsinovoi CL, Klemmer P, Liu K, He K: Intakes of long-chain omega-3 polyunsaturated fatty acids and non-fried fish in relation to incidence of
chronic kidney disease in young adults: A 25-year follow-up. Eur J Nutr 59: 399–407, 2020 31175412
58. Ramezankhani A, Tohidi M, Azizi F, Hadaegh F: Application of survival tree analysis for exploration of potential interactions between predictors of incident
chronic kidney disease: A 15-year follow-up study. J Transl Med 15: 240, 2017 29183386
59. Rebholz CM, Anderson CA, Grams ME, Bazzano LA, Crews DC, Chang AR, et al.: Relationship of the American Heart Association’s impact goals (life’s simple 7) with risk of
chronic kidney disease: Results from the Atherosclerosis Risk in Communities (ARIC) cohort study. J Am Heart Assoc 5: e003192, 2016 27053058
60. Rebholz CM, Coresh J, Grams ME, Steffen LM, Anderson CA, Appel LJ, et al.: Dietary acid load and incident
chronic kidney disease: Results from the ARIC study. Am J Nephrol 42: 427–435, 2015 26789417
61. Rebholz CM, Crews DC, Grams ME, Steffen LM, Levey AS, Miller ER 3rd, et al.: DASH (Dietary Approaches to Stop Hypertension)
diet and risk of subsequent kidney disease. Am J Kidney Dis 68: 853–861, 2016 27519166
62. Rebholz CM, Young BA, Katz R, Tucker KL, Carithers TC, Norwood AF, et al.: Patterns of beverages consumed and risk of incident kidney disease. Clin J Am Soc Nephrol 14: 49–56, 2019 30591520
63. Ryoo J-H, Choi J-M, Oh C-M, Kim M-G: The association between uric acid and
chronic kidney disease in Korean men: A 4-year follow-up study. J Korean Med Sci 28: 855–860, 2013 23772149
64. Schaeffner ES, Kurth T, de Jong PE, Glynn RJ, Buring JE, Gaziano JM:
Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Arch Intern Med 165: 1048–1053, 2005 15883245
65. Shankar A, Klein R, Klein BE: The association among
smoking, heavy drinking, and
chronic kidney disease. Am J Epidemiol 164: 263–271, 2006 16775042
66. Sugiura T, Takase H, Ohte N, Dohi Y: Dietary salt intake is a significant determinant of impaired kidney function in the general population. Kidney Blood Press Res 43: 1245–1254, 2018 30078009
67. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS: Uric acid and incident kidney disease in the community. J Am Soc Nephrol 19: 1204–1211, 2008 18337481
68. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al.: Risk factors for
chronic kidney disease in a community-based population: A 10-year follow-up study. Kidney Int 71: 159–166, 2007 17136030
69. Yoon CY, Noh J, Lee J, Kee YK, Seo C, Lee M, et al.: High and low sodium intakes are associated with incident
chronic kidney disease in patients with normal renal function and hypertension. Kidney Int 93: 921–931, 2018 29198468
70. Yoon CY, Park JT, Jhee JH, Noh J, Kee YK, Seo C, et al.: High dietary phosphorus density is a risk factor for incident
chronic kidney disease development in diabetic subjects: A community-based prospective cohort study. Am J Clin Nutr 106: 311–321, 2017 28592606
71. Yuzbashian E, Asghari G, Mirmiran P, Zadeh-Vakili A, Azizi F: Sugar-sweetened beverage consumption and risk of incident
chronic kidney disease: Tehran Lipid and Glucose Study. Nephrology (Carlton) 21: 608–616, 2016 26439668
72. Kanda E, Muneyuki T, Suwa K, Nakajima K:
Alcohol and
exercise affect declining kidney function in healthy males regardless of obesity: A prospective cohort study. PLoS One 10: e0134937, 2015 26237314
73. Rebholz CM, Tin A, Liu Y, Kuczmarski MF, Evans MK, Zonderman AB, et al.: Dietary magnesium and kidney function decline: The healthy aging in neighborhoods of diversity across the Life Span Study. Am J Nephrol 44: 381–387, 2016 27771720
74. Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, et al.: Incidence of
chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS One 7: e45304, 2012 23028919
75. Bash LD, Astor BC, Coresh J: Risk of incident ESRD: A comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 55: 31–41, 2010 19932544
76. Hallan SI, Orth SR:
Smoking is a risk factor in the progression to kidney failure. Kidney Int 80: 516–523, 2011 21677635
77. Jafar TH, Jin A, Koh WP, Yuan JM, Chow KY: Physical activity and risk of end-stage kidney disease in the Singapore Chinese Health Study. Nephrology (Carlton) 20: 61–67, 2015 25346108
78. Lew QJ, Jafar TH, Jin A, Yuan JM, Koh WP: Consumption of coffee but not of other caffeine-containing beverages reduces the risk of end-stage renal disease in the Singapore Chinese Health study. J Nutr 148: 1315–1322, 2018 29986029
79. Lew QJ, Jafar TH, Koh HW, Jin A, Chow KY, Yuan JM, et al.: Red meat intake and risk of ESRD. J Am Soc Nephrol 28: 304–312, 2017 27416946
80. Lipworth L, Mumma MT, Cavanaugh KL, Edwards TL, Ikizler TA, Tarone RE, et al.: Incidence and predictors of end stage renal disease among low-income blacks and whites. PLoS One 7: e48407, 2012 23110237
81. Pscheidt C, Nagel G, Zitt E, Kramar R, Concin H, Lhotta K: Sex- and time-dependent patterns in risk factors of end-stage renal disease: A large Austrian cohort with up to 20 years of follow-up. PLoS One 10: e0135052, 2015 26322515
82. Rebholz CM, Grams ME, Steffen LM, Crews DC, Anderson CA, Bazzano LA, et al.:
Diet soda consumption and risk of incident end stage renal disease. Clin J Am Soc Nephrol 12: 79–86, 2017 27797893
83. Reynolds K, Gu D, Chen J, Tang X, Yau CL, Yu L, et al.:
Alcohol consumption and the risk of end-stage renal disease among Chinese men. Kidney Int 73: 870–876, 2008 18185503
84. Smyth A, Griffin M, Yusuf S, Mann JF, Reddan D, Canavan M, et al.:
Diet and major renal outcomes: A prospective cohort study. The NIH-AARP
Diet and Health study. J Ren Nutr 26: 288–298, 2016 26975776
85. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL:
Lifestyle factors, obesity and the risk of
chronic kidney disease. Epidemiology 14: 479–487, 2003 12843775
86. Van Noordenne ND, Olde Engberink RHG, Van Den Hoek TC, Van Den Born BJH, Vogt L: Associations of 15-year average potassium intake with long term renal outcome in the outpatient clinical setting. Nephrol Dial Transplant 31: i11, 2016
87. Jin A, Koh W-P, Chow KY, Yuan J-M, Jafar TH:
Smoking and risk of kidney failure in the Singapore Chinese health study. PLoS One 8: e62962, 2013 23671645
88. Wadén J, Tikkanen HK, Forsblom C, Harjutsalo V, Thorn LM, Saraheimo M, et al.; FinnDiane Study Group: Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: The FinnDiane study. Diabetologia 58: 929–936, 2015 25634228
89. Cirillo M, Cavallo P, Bilancio G, Lombardi C, Terradura Vagnarelli O, Laurenzi M: Low protein intake in the population: Low risk of kidney function decline but high risk of mortality. J Ren Nutr 28: 235–244, 2018 29439930
90. Deriaz D, Guessous I, Vollenweider P, Devuyst O, Burnier M, Bochud M, et al.: Estimated 24-h urinary sodium and sodium-to-potassium ratio are predictors of kidney function decline in a population-based study. J Hypertens 37: 1853–1860, 2019 30964826
91. Esmeijer K, Geleijnse J, De Fijter J, Kromhout D, Hoogeveen E: High protein intake accelerates kidney function decline in post-myocardial infarction patients: The Alpha Omega cohort study. Nephrol Dial Transplant 33[Suppl 1]: i469, 2018
92. Halbesma N, Bakker SJ, Jansen DF, Stolk RP, De Zeeuw D, De Jong PE, et al.; PREVEND Study Group: High protein intake associates with cardiovascular events but not with loss of renal function. J Am Soc Nephrol 20: 1797–1804, 2009 19443643
93. Herber-Gast GC, van Essen H, Verschuren WM, Stehouwer CD, Gansevoort RT, Bakker SJ, et al.: Coffee and tea consumption in relation to estimated glomerular filtration rate: Results from the population-based longitudinal Doetinchem Cohort study. Am J Clin Nutr 103: 1370–1377, 2016 26984487
94. Herber-Gast GM, Biesbroek S, Verschuren WMM, Stehouwer CD, Gansevoort RT, Bakker SJ, et al.: Association of dietary protein and dairy intakes and change in renal function: Results from the population-based longitudinal doetinchem cohort study. Am J Clin Nutr 104: 1712–1719, 2016 27935525
95. Herber-Gast GM, Boersma M, Verschuren WMM, Stehouwer CDA, Gansevoort RT, Bakker SJL, et al.: Consumption of whole grains, fruit and vegetables is not associated with indices of renal function in the population-based longitudinal Doetinchem study. Br J Nutr 118: 375–382, 2017 28901886
96. Hirahatake KM, Jacobs DR, Gross MD, Bibbins-Domingo KB, Shlipak MG, Mattix-Kramer H, et al.: The association of serum carotenoids, tocopherols, and ascorbic acid with rapid kidney function decline: The Coronary Artery Risk Development in Young Adults (CARDIA) study. J Ren Nutr 29: 65–73, 2019 30098859
97. Jhee JH, Kee YK, Park S, Kim H, Park JT, Han SH, et al.: High-protein
diet with renal hyperfiltration is associated with rapid decline rate of renal function: A community-based prospective cohort study. Nephrol Dial Transplant 35: 98–106, 2020 31172186
98. Knight EL, Stampfer MJ, Hankinson SE, Spiegelman D, Curhan GC: The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med 138: 460–467, 2003 12639078
99. Krop JS, Coresh J, Chambless LE, Shahar E, Watson RL, Szklo M, et al.: A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: The Atherosclerosis Risk in Communities study. Arch Intern Med 159: 1777–1783, 1999 10448782
100. Lin J, Curhan GC: Associations of sugar and artificially sweetened soda with albuminuria and kidney function decline in women. Clin J Am Soc Nephrol 6: 160–166, 2011 20884773
101. Lin J, Hu FB, Curhan GC: Associations of
diet with albuminuria and kidney function decline. Clin J Am Soc Nephrol 5: 836–843, 2010 20299364
102. Malhotra R, Lipworth L, Cavanaugh KL, Young BA, Tucker KL, Carithers TC, et al.: Protein intake and long-term change in glomerular filtration rate in the Jackson Heart Study. J Ren Nutr 28: 245–250, 2018 29452887
103. Menon V, Katz R, Mukamal K, Kestenbaum B, de Boer IH, Siscovick DS, et al.:
Alcohol consumption and kidney function decline in the elderly:
Alcohol and kidney disease. Nephrol Dial Transplant 25: 3301–3307, 2010 20400446
104. Ohta Y, Tsuchihashi T, Kiyohara K, Oniki H: High salt intake promotes a decline in renal function in hypertensive patients: A 10-year observational study. Hypertens Res 36: 172–176, 2013 23051657
105. White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ:
Alcohol consumption and 5-year onset of
chronic kidney disease: The AusDiab study. Nephrol Dial Transplant 24: 2464–2472, 2009 19307230
106. Barbato A, D’Elia L, Perna L, Molisso A, Iacone R, Strazzullo P, et al.: Increased microalbuminuria risk in male cigarette smokers: Results from the “Olivetti Heart Study” after 8 years follow-up. Kidney Blood Press Res 44: 33–42, 2019 30808835
107. Chang A, Van Horn L, Jacobs DR Jr., Liu K, Muntner P, Newsome B, et al.:
Lifestyle-related factors, obesity, and incident microalbuminuria: The CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Kidney Dis 62: 267–275, 2013 23601954
108. Forman JP, Scheven L, de Jong PE, Bakker SJ, Curhan GC, Gansevoort RT: Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation 125: 3108–3116, 2012 22711274
109. Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, Miller ER 3rd: Direct, progressive association of cardiovascular risk factors with incident proteinuria: Results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med 165: 2299–2304, 2005 16246998
110. Kimura Y, Yamamoto R, Shinzawa M, Isaka Y, Iseki K, Yamagata K, et al.:
Alcohol consumption and incidence of proteinuria: A retrospective cohort study. Clin Exp Nephrol 22: 1133–1142, 2018 29600409
111. Maeda I, Hayashi T, Sato KK, Koh H, Harita N, Nakamura Y, et al.: Cigarette
smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. Clin J Am Soc Nephrol 6: 2462–2469, 2011 21885794
112. O’Seaghdha CM, Hwang S-J, Upadhyay A, Meigs JB, Fox CS: Predictors of incident albuminuria in the Framingham Offspring cohort. Am J Kidney Dis 56: 852–860, 2010 20599306
113. Uehara S, Hayashi T, Kogawa Sato K, Kinuhata S, Shibata M, Oue K, et al.: Relationship between
alcohol drinking pattern and risk of proteinuria: The Kansai healthcare study. J Epidemiol 26: 464–470, 2016 26902169
114. Wakasugi M, Kazama J, Narita I, Iseki K, Fujimoto S, Moriyama T, et al.: Association between overall
lifestyle changes and the incidence of proteinuria: A population-based, cohort study. Intern Med 56: 1475–1484, 2017 28626171
115. Wakasugi M, Kazama JJ, Yamamoto S, Kawamura K, Narita I: A combination of healthy
lifestyle factors is associated with a decreased incidence of
chronic kidney disease: A population-based cohort study. Hypertens Res 36: 328–333, 2013 23171953
116. Wen J, Hao J, Zhang Y, Liang Y, Li S, Wang F, et al.: Fresh fruit consumption and risk of incident albuminuria among rural Chinese adults: A village-based prospective cohort study. PLoS One 13: e0197917, 2018 29795700
117. Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, et al.: Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: Systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 349: g4490, 2014 25073782
118. Crowe FL, Roddam AW, Key TJ, Appleby PN, Overvad K, Jakobsen MU, et al.; European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart Study Collaborators: Fruit and vegetable intake and mortality from ischaemic heart disease: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study. Eur Heart J 32: 1235–1243, 2011 21245490
119. Chauveau P, Koppe L, Combe C, Lasseur C, Trolonge S, Aparicio M: Vegetarian diets and
chronic kidney disease. Nephrol Dial Transplant 34: 199–207, 2019 29982610
120. O’Donnell M, Mente A, Rangarajan S, McQueen MJ, O’Leary N, Yin L, et al.; PURE Investigators: Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: Prospective cohort study. BMJ 364: l772, 2019 30867146
121. Vinceti M, Filippini T, Crippa A, de Sesmaisons A, Wise LA, Orsini N: Meta-analysis of potassium intake and the risk of stroke. J Am Heart Assoc 5: e004210, 2016 27792643
122. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, et al.: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 277: 1624–1632, 1997 9168293
123. Geleijnse JM, Kok FJ, Grobbee DE: Blood pressure response to changes in sodium and potassium intake: A metaregression analysis of randomised trials. J Hum Hypertens 17: 471–480, 2003 12821954
124. Smyth A, Dunkler D, Gao P, Teo KK, Yusuf S, O’Donnell MJ, et al.; ONTARGET and TRANSCEND investigators: The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney Int 86: 1205–1212, 2014 24918156
125. Clase CM, Carrero J-J, Ellison DH, Grams ME, Hemmelgarn BR, Jardine MJ, et al.; Conference Participants: Potassium homeostasis and management of dyskalemia in kidney diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 97: 42–61, 2020 31706619
126. McMahon EJ, Campbell KL, Bauer JD, Mudge DW: Altered dietary salt intake for people with
chronic kidney disease. Cochrane Database Syst Rev 2: CD010070, 2015 25691262
127. Stolarz-Skrzypek K, Staessen JA: Reducing salt intake for prevention of cardiovascular disease--times are changing. Adv Chronic Kidney Dis 22: 108–115, 2015 25704347
128. Mu M, Xu L-F, Hu D, Wu J, Bai M-J: Dietary patterns and overweight/obesity: A review article. Iran J Public Health 46: 869–876, 2017 28845396
129. Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G: A systematic review and meta-analysis suggests obesity predicts onset of
chronic kidney disease in the general population. Kidney Int 91: 1224–1235, 2017 28187985
130. Mozaffarian D: Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: A comprehensive review. Circulation 133: 187–225, 2016 26746178
131. Kubota Y, Iso H, Yamagishi K, Sawada N, Tsugane S; JPHC Study Group (Japan Public Health Center): Daily total physical activity and incident cardiovascular disease in Japanese men and women: Japan Public Health Center-Based Prospective Study. Circulation 135: 1471–1473, 2017 28396381
132. Chomistek AK, Cook NR, Rimm EB, Ridker PM, Buring JE, Lee IM: Physical activity and incident cardiovascular disease in women: Is the relation modified by level of global cardiovascular risk? J Am Heart Assoc 7: e008234, 2018 29895589
133. Lear SA, Hu W, Rangarajan S, Gasevic D, Leong D, Iqbal R, et al.: The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: The PURE study. Lancet 390: 2643–2654, 2017 28943267
134. Robinson-Cohen C, Katz R, Mozaffarian D, Dalrymple LS, de Boer I, Sarnak M, et al.: Physical activity and rapid decline in kidney function among older adults. Arch Intern Med 169: 2116–2123, 2009 20008696
135. Zelle DM, Klaassen G, van Adrichem E, Bakker SJ, Corpeleijn E, Navis G: Physical inactivity: A risk factor and target for intervention in renal care. Nat Rev Nephrol 13: 152–168, 2017 28138130
136. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al.: 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of cardiology/American heart association task force on clinical practice guidelines [published correction appears in
J Am Coll Cardiol 74: 1429–1430, 2019]. J Am Coll Cardiol 74: e177–e232, 2019 30894318
137. Milam RH:
Exercise guidelines for
chronic kidney disease patients. J Ren Nutr 26: e23–e25, 2016 27318109
138. Latchoumycandane C, Nagy LE, McIntyre TM: Chronic ethanol ingestion induces oxidative kidney injury through taurine-inhibitable inflammation. Free Radic Biol Med 69: 403–416, 2014 24412858
139. Fan Z, Yun J, Yu S, Yang Q, Song L:
Alcohol consumption can be a “double-edged sword” for
chronic kidney disease patients. Med Sci Monit 25: 7059–7072, 2019 31538630
140. Lin M, Su Q, Huang H, Zheng Y, Wen J, Yao J, et al.:
Alcohol consumption and the risk for renal hyperfiltration in the general Chinese population. Eur J Clin Nutr 71: 500–505, 2017 27804962
141. Roerecke M, Rehm J:
Alcohol consumption, drinking patterns, and ischemic heart disease: A narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med 12: 182, 2014 25567363
142. Jespersen T, Kruse N, Mehta T, Kuwabara M, Noureddine L, Jalal D: Light wine consumption is associated with a lower odd for cardiovascular disease in
chronic kidney disease. Nutr Metab Cardiovasc Dis 28: 1133–1139, 2018 30143406
143. Dunkler D, Kohl M, Heinze G, Teo KK, Rosengren A, Pogue J, et al.; ONTARGET Investigators: Modifiable
lifestyle and social factors affect
chronic kidney disease in high-risk individuals with type 2 diabetes mellitus. Kidney Int 87: 784–791, 2015 25493953
144. Baranchuk A, Haseeb S, Alexander B:
Alcohol consumption guidelines: International discrepancies and variations. BMJ 361: k1630, 2018
145. Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y, et al.: Cigarette
smoking and
chronic kidney disease in the general population: A systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant 32: 475–487, 2017 28339863
146. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD: Metabolic syndrome and kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol 6: 2364–2373, 2011 21852664
147. Janssen WM, Hillege H, Pinto-Sietsma SJ, Bak AA, De Zeeuw D, de Jong PE; PREVEND Study Group. Prevention of Renal and Vascular End-stage Disease: Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population. Clin Chem Lab Med 38: 1107–1110, 2000 11156337
148. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al.: ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355: i4919, 2016 27733354
149. Wei Y, Wang Y, Di Q, Choirat C, Wang Y, Koutrakis P, et al.: Short term exposure to fine particulate matter and hospital admission risks and costs in the medicare population: Time stratified, case crossover study. BMJ 367: l6258, 2019 31776122
150. Blum MF, Surapaneni A, Stewart JD, Liao D, Yanosky JD, Whitsel EA, et al.: Particulate matter and albuminuria, glomerular filtration rate, and incident CKD. Clin J Am Soc Nephrol 15: 311–319, 2020
151. Whittaker CF, Miklich MA, Patel RS, Fink JC: Medication safety principles and practice in CKD. Clin J Am Soc Nephrol 13: 1738–1746, 2018 29915131
152. Johri N, Jacquillet G, Unwin R: Heavy metal poisoning: The effects of cadmium on the kidney. Biometals 23: 783–792, 2010 20354761
